Clinical Trial: Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic Hyperplasia

U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07870759) titled 'Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic Hyperplasia' on Oct. 06.

Brief Summary: Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic Hyperplasia

Study Start Date: Nov. 09

Study Type: INTERVENTIONAL

Condition: Benign Prostatic Hyperplasia

Intervention: DRUG: Finasteride 5 mg Tablet, single dose

Finasteride 5mg administered orally once daily

DRUG: Tamsulosin 0.4Mg Capsule

Tamsulosin 0.4mg capsule administered orally once daily

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Il-Yang Pharm. Co., Ltd.

Disclaimer: C...